Does EVEROLIMUS Cause Metastases to lung? 522 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 522 reports of Metastases to lung have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.3% of all adverse event reports for EVEROLIMUS.
522
Reports of Metastases to lung with EVEROLIMUS
1.3%
of all EVEROLIMUS reports
164
Deaths
153
Hospitalizations
How Dangerous Is Metastases to lung From EVEROLIMUS?
Of the 522 reports, 164 (31.4%) resulted in death, 153 (29.3%) required hospitalization, and 40 (7.7%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 522 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
CARBOPLATIN (369)
Which EVEROLIMUS Alternatives Have Lower Metastases to lung Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE